Jennifer Chien
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jennifer Chien
The proxy statement of Rhythm Pharmaceuticals, Inc. reports total compensation of $1,086,675 for Jennifer Chien in fiscal 2022, including a base salary of $430,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Rhythm Pharmaceuticals, Inc. (RYTM)
Proxy statement
Start not stated–2023-04-27
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $430,000 | $1,086,675 |
| 2021 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $395,000 | $2,081,452 |
| 2020 | Rhythm Pharmaceuticals, Inc. (RYTM) | Executive Vice President, Head of North America | $45,577 | $1,819,617 |
Recent activity
No call appearances or filed executive changes recorded yet.